201 related articles for article (PubMed ID: 35914786)
1. Timing and Predictors of Incident Cardiovascular Disease in Systemic Lupus Erythematosus: Risk Occurs Early and Highlights Racial Disparities.
Garg S; Bartels CM; Bao G; Helmick CG; Drenkard C; Lim SS
J Rheumatol; 2023 Jan; 50(1):84-92. PubMed ID: 35914786
[TBL] [Abstract][Full Text] [Related]
2. Racial disparities in age at time of cardiovascular events and cardiovascular-related death in patients with systemic lupus erythematosus.
Scalzi LV; Hollenbeak CS; Wang L
Arthritis Rheum; 2010 Sep; 62(9):2767-75. PubMed ID: 20506536
[TBL] [Abstract][Full Text] [Related]
3. Mortality and cardiovascular burden of systemic lupus erythematosus in a US population-based cohort.
Bartels CM; Buhr KA; Goldberg JW; Bell CL; Visekruna M; Nekkanti S; Greenlee RT
J Rheumatol; 2014 Apr; 41(4):680-7. PubMed ID: 24532834
[TBL] [Abstract][Full Text] [Related]
4. Racial Disparities in Mortality Associated with Systemic Lupus Erythematosus - Fulton and DeKalb Counties, Georgia, 2002-2016.
Lim SS; Helmick CG; Bao G; Hootman J; Bayakly R; Gordon C; Drenkard C
MMWR Morb Mortal Wkly Rep; 2019 May; 68(18):419-422. PubMed ID: 31071073
[TBL] [Abstract][Full Text] [Related]
5. Differences in subclinical cardiovascular disease between African American and Caucasian women with systemic lupus erythematosus.
Rhew EY; Manzi SM; Dyer AR; Kao AH; Danchenko N; Barinas-Mitchell E; Sutton-Tyrrell K; McPherson DD; Pearce W; Edmundowicz D; Kondos GT; Ramsey-Goldman R
Transl Res; 2009 Feb; 153(2):51-9. PubMed ID: 19138649
[TBL] [Abstract][Full Text] [Related]
6. Initial disease severity, cardiovascular events and all-cause mortality among patients with systemic lupus erythematosus.
Li D; Yoshida K; Feldman CH; Speyer C; Barbhaiya M; Guan H; Solomon DH; Everett BM; Costenbader KH
Rheumatology (Oxford); 2020 Mar; 59(3):495-504. PubMed ID: 31321417
[TBL] [Abstract][Full Text] [Related]
7. Race/Ethnicity and Cardiovascular Events Among Patients With Systemic Lupus Erythematosus.
Barbhaiya M; Feldman CH; Guan H; Gómez-Puerta JA; Fischer MA; Solomon DH; Everett B; Costenbader KH
Arthritis Rheumatol; 2017 Sep; 69(9):1823-1831. PubMed ID: 28598016
[TBL] [Abstract][Full Text] [Related]
8. Does SLE widen or narrow race/ethnic disparities in the risk of five co-morbid conditions? Evidence from a community-based outpatient care system.
Falasinnu T; Chaichian Y; Li J; Chung S; Waitzfelder BE; Fortmann SP; Palaniappan L; Simard JF
Lupus; 2019 Dec; 28(14):1619-1627. PubMed ID: 31660790
[TBL] [Abstract][Full Text] [Related]
9. Cutaneous lupus erythematosus and systemic lupus erythematosus are associated with clinically significant cardiovascular risk: a Danish nationwide cohort study.
Hesselvig JH; Ahlehoff O; Dreyer L; Gislason G; Kofoed K
Lupus; 2017 Jan; 26(1):48-53. PubMed ID: 27235406
[TBL] [Abstract][Full Text] [Related]
10. Racial Disparities in the Incidence of Primary Chronic Cutaneous Lupus Erythematosus in the Southeastern US: The Georgia Lupus Registry.
Drenkard C; Parker S; Aspey LD; Gordon C; Helmick CG; Bao G; Lim SS
Arthritis Care Res (Hoboken); 2019 Jan; 71(1):95-103. PubMed ID: 29669194
[TBL] [Abstract][Full Text] [Related]
11. Population-based incidence and prevalence of systemic lupus erythematosus: the Michigan Lupus Epidemiology and Surveillance program.
Somers EC; Marder W; Cagnoli P; Lewis EE; DeGuire P; Gordon C; Helmick CG; Wang L; Wing JJ; Dhar JP; Leisen J; Shaltis D; McCune WJ
Arthritis Rheumatol; 2014 Feb; 66(2):369-78. PubMed ID: 24504809
[TBL] [Abstract][Full Text] [Related]
12. Racial and Ethnic Differences in the Prevalence and Time to Onset of Manifestations of Systemic Lupus Erythematosus: The California Lupus Surveillance Project.
Maningding E; Dall'Era M; Trupin L; Murphy LB; Yazdany J
Arthritis Care Res (Hoboken); 2020 May; 72(5):622-629. PubMed ID: 31115180
[TBL] [Abstract][Full Text] [Related]
13. Sociodemographic profiles and organ damage accural in the Black Women's Experience Living with Lupus study.
Martz CD; Webb-Detiege T; Danila MI; Chae DH
Lupus; 2024 Jan; 33(1):17-25. PubMed ID: 38048450
[TBL] [Abstract][Full Text] [Related]
14. Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus Registry.
Plantinga L; Lim SS; Patzer R; McClellan W; Kramer M; Klein M; Pastan S; Gordon C; Helmick C; Drenkard C
Arthritis Care Res (Hoboken); 2016 Mar; 68(3):357-65. PubMed ID: 26239749
[TBL] [Abstract][Full Text] [Related]
15. Racial Discrimination, Disease Activity, and Organ Damage: The Black Women's Experiences Living With Lupus (BeWELL) Study.
Chae DH; Martz CD; Fuller-Rowell TE; Spears EC; Smith TTG; Hunter EA; Drenkard C; Lim SS
Am J Epidemiol; 2019 Aug; 188(8):1434-1443. PubMed ID: 31062841
[TBL] [Abstract][Full Text] [Related]
16. Cardiovascular event in systemic lupus erythematosus in northern Sweden: incidence and predictors in a 7-year follow-up study.
Bengtsson C; Ohman ML; Nived O; Rantapää Dahlqvist S
Lupus; 2012 Apr; 21(4):452-9. PubMed ID: 22065097
[TBL] [Abstract][Full Text] [Related]
17. The Incidence and Prevalence of Systemic Lupus Erythematosus in San Francisco County, California: The California Lupus Surveillance Project.
Dall'Era M; Cisternas MG; Snipes K; Herrinton LJ; Gordon C; Helmick CG
Arthritis Rheumatol; 2017 Oct; 69(10):1996-2005. PubMed ID: 28891237
[TBL] [Abstract][Full Text] [Related]
18. Prevalence and correlation of conventional and lupus-specific risk factors for cardiovascular disease in Chinese systemic lupus erythematosus patients.
Yang L; Tao J; Tang X; Wang Y; He X; Xu G; Ren Y; Tu Y
J Eur Acad Dermatol Venereol; 2012 Jan; 26(1):95-101. PubMed ID: 21851424
[TBL] [Abstract][Full Text] [Related]
19. Association of African-American ethnicity and smoking status with total and individual damage index in systemic lupus erythematosus.
Kallas R; Li J; Petri M
Clin Rheumatol; 2020 Feb; 39(2):365-373. PubMed ID: 31705325
[TBL] [Abstract][Full Text] [Related]
20. Prevalence of major adverse cardiovascular events among Saudi patients with systemic lupus erythematosus compared with the general population: updates from the national SLE and PURE cohorts.
Almaghlouth I; Bohuliga KG; Alanazi B; Alhawsa BK; Alabdulkareem AM; Alqarawi W; Asfina KN; Khalil N; Ali HH; Bedaiwi M; Aboabat A; Su J; Alam TA; Alanazi FG; Omair MA; Alarfaj AS; Almalag HM; Al Shamiri M; Alhabib KF
Lupus Sci Med; 2024 May; 11(1):. PubMed ID: 38789277
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
